key: cord-0853594-u2t87qrz authors: Rana, Muhammad Suleman; Usman, Muhammad; Alam, Muhammad Masroor; Ikram, Aamer; Salman, Muhammad; Umair, Massab title: Impact of previous SARS-CoV-2 infection on the rate of mortality in dengue. A preliminary report from Pakistan date: 2022-01-23 journal: J Infect DOI: 10.1016/j.jinf.2022.01.027 sha: 458f5a10e86fd670ad4f186960ea45d880caf17e doc_id: 853594 cord_uid: u2t87qrz nan Similarly, in Pakistan, the toll of confirmed COVID-19 cases reached 12,82,510 including 28,668 deaths since 26 February 2020 [2] . On the other hand, the incidence of dengue has grown dramatically around the world in recent decades. It is estimated that 390 million dengue infections and 40,000 related deaths occurred per year with 70% of the world's dengue burden being in Asia. Out of 390 million dengue cases, only 24% manifest clinical symptoms, and the other 76% remain asymptomatic. The total number of dengue cases reported to WHO increased over 10 fold from 0.5 million cases in 2000 to over 5.2 million in 2019 [3] . In 2021, 1 316 518 dengue cases have been reported, the majority of the cases are from Brazil, India, Vietnam, Peru and Philippines, Pakistan, Bangladesh, Nepal Colombia, and Vietnam [4] . Unfortunately, dengue is endemic in Pakistan since 1994, when the first laboratoryconfirmed dengue outbreak occurred in Karachi city of Sindh province. From 1994 to 2009 localized dengue outbreaks with 8549 cases including 215 deaths were reported in Karachi, Pakistan. During the last decade 2010-2020, a yearly outbreak of dengue has more frequent and expanded to every corner of the country with 144,855 cases including 625 deaths. In Pakistan the largest ever dengue outbreak was reported in 2019, infecting over 52485 individuals with 75 related deaths [5] . During the current year, sporadic dengue cases were detected since February 2021. However, this dengue outbreak gets intensified during the post moon soon season from September to November 2021. As of 23 November 2021, a total of 2,36,773 suspected and 50,120 confirmed dengue cases including 227 deaths have been reported in Pakistan. 50% (25000/50120) of the total cases were reported from Punjab province. Province-wide distribution of dengue cases showed that over 85% of total cases reported by each province are from the highly populous cities such as Lahore, Karachi, Peshawar, Quetta, Islamabad, and Muzaffarabad, which are considered as the hotspot for dengue outbreaks for the last many years. It is speculated that the actual number of dengue cases and deaths might be high than reported as most dengue cases remain asymptomatic and become a source of infection for the community. According to the current data, the rate of mortality due to dengue is very high as compared to previous dengue outbreaks. It year of age group. The cross-reactivity of COVID-19 and dengue antibodies has already been reported [8] . In our previous study, we have already reported the coinfection of dengue and COVID-19 with unfavorable outcomes. A recently published study in the journal of clinical infectious diseases also reported that the previous dengue infection increases the risk of severe COVID-19 due to the cross-reactivity of non-neutralizing antibodies [9] . If the previous infection of dengue increases the risk of severe COVID-19 and the previous exposer to covid-19 ultimately increases the risk of severe dengue as indicated by the results of the present study. Both COVID-19 and dengue are significant public health problems, especially in dengue-endemic countries. The present study explored the preliminary observational evidence that the previous COVID-19 infection might increase the risk of mortality due to dengue virus infection. The Bidirectional impact of ADE in COVID-19 versus dengue is a growing concern. This phenomenon is enormously important not only for the understanding of viral pathogenesis but also for developing antiviral strategies such as vaccines for COVID-19 and dengue. Rigorous research work on deep cellular and immunological aspects from dengue-endemic countries is needed to further elucidate the effect of antibodies cross-reactivity in patients having pre or post exposer to COVID-19 and dengue. COVID-19 and alarming dengue co-epidemics in the dilapidated healthcare system in Pakistan: Where to focus! World Health Organization, Dengue, and severe dengue Prevention, and control of escalating dengue epidemics in Pakistan Serotype diversity of dengue virus reveals the predominance of type 2 in Pakistan during 2019 Dengue infection in Pakistan: not an isolated problem Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study The authors have no funding to report The authors declared that there is no conflict of interest.